Scott Addonizio
Chief Operating Officer bij M.A. Med Alliance SA
Profiel
Scott Addonizio is currently a General Partner at Cultivation Capital LLC, Chief Operating Officer at M.A.
Med Alliance SA, and a Board Member at Simpson Interventions, Inc. Previously, he worked as a Senior Vice President & COO at OrbusNeich Medical Technology Co. Ltd.
from 2016 to 2020.
He received his undergraduate degree from Michigan State University in 1995 and his graduate degree from Miami Herbert Business School in 1998.
Actieve functies van Scott Addonizio
| Bedrijven | Functie | Begin |
|---|---|---|
M.A. Med Alliance SA
 M.A. Med Alliance SA Packaged SoftwareTechnology Services M.A. Med Alliance SA is a company based in Nyon, Switzerland that specializes in developing innovative technology and commercializing advanced drug device combination products for the treatment of coronary and peripheral artery disease. The Swiss company's flagship product is the Selution SLR™ DEB, which is a novel sirolimus-eluting balloon platform technology. The CEO of the company is Jeffrey Bryan Jump. | Chief Operating Officer | - |
Cultivation Capital LLC
 Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | - |
| Simpson Interventions , Inc. | Director/Board Member | - |
Eerdere bekende functies van Scott Addonizio
| Bedrijven | Functie | Einde |
|---|---|---|
OrbusNeich Medical Technology Co. Ltd.
 OrbusNeich Medical Technology Co. Ltd. Medical SpecialtiesHealth Technology OrbusNeich Medical Technology Co. Ltd. is a Chinese medical device company that specializes in the treatment of vascular diseases. The private company is based in Hong Kong, Hong Kong, and has worldwide locations. The company's range of innovative devices includes balloons, stents, and specialty catheters that help simplify complex procedures for difficult lesions during coronary and peripheral procedures. OrbusNeich is committed to improving the long-term quality of life for patients through patient education. Bruce Wayne Johnson has been the CEO of the company since 2002. | Chief Operating Officer | 31-01-2020 |
Opleiding van Scott Addonizio
| Michigan State University | Undergraduate Degree |
| Miami Herbert Business School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
OrbusNeich Medical Technology Co. Ltd.
OrbusNeich Medical Technology Co. Ltd. Medical SpecialtiesHealth Technology OrbusNeich Medical Technology Co. Ltd. is a Chinese medical device company that specializes in the treatment of vascular diseases. The private company is based in Hong Kong, Hong Kong, and has worldwide locations. The company's range of innovative devices includes balloons, stents, and specialty catheters that help simplify complex procedures for difficult lesions during coronary and peripheral procedures. OrbusNeich is committed to improving the long-term quality of life for patients through patient education. Bruce Wayne Johnson has been the CEO of the company since 2002. | Health Technology |
Cultivation Capital LLC
Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Finance |
M.A. Med Alliance SA
M.A. Med Alliance SA Packaged SoftwareTechnology Services M.A. Med Alliance SA is a company based in Nyon, Switzerland that specializes in developing innovative technology and commercializing advanced drug device combination products for the treatment of coronary and peripheral artery disease. The Swiss company's flagship product is the Selution SLR™ DEB, which is a novel sirolimus-eluting balloon platform technology. The CEO of the company is Jeffrey Bryan Jump. | Technology Services |
| Simpson Interventions , Inc. |
